BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2864751)

  • 21. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
    Achyuthan KE; Mary A; Greenberg CS
    J Biol Chem; 1988 Oct; 263(28):14296-301. PubMed ID: 2902081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of fibrinogen on fibrin polymerization. Ultracentrifugation studies.
    Preissner KT; Rötker J; Selmayr E; Fasold H; Müller-Berghaus G
    Biochim Biophys Acta; 1985 Jul; 829(3):358-64. PubMed ID: 4005267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation in the sand crab (Ovalipes bipustulatus).
    Madaras F; Parkin JD; Castaldi PA
    Thromb Haemost; 1979 Aug; 42(2):734-42. PubMed ID: 505375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble fibrin consists of fibrin oligomers of heterogeneous distribution.
    Rötker J; Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 Mar; 155(3):583-8. PubMed ID: 3956500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
    Greenberg CS; Miraglia CC
    Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 28. The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.
    Veklich Y; Ang EK; Lorand L; Weisel JW
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1438-42. PubMed ID: 9465033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of gamma A/gamma ' fibrinogen in plasma factor XIII activation.
    Moaddel M; Falls LA; Farrell DH
    J Biol Chem; 2000 Oct; 275(41):32135-40. PubMed ID: 10913112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.
    Poole LG; Kopec AK; Groeneveld DJ; Pant A; Baker KS; Cline-Fedewa HM; Flick MJ; Luyendyk JP
    Blood; 2021 May; 137(18):2520-2531. PubMed ID: 33569603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adduct formation between soluble fibrin monomers and elastin.
    Rabaud M; Lefebvre F; Martin MT; Aprahamian M; Schmitthaeusler R; Cazenave JP
    Biomaterials; 1987 May; 8(3):217-22. PubMed ID: 2886158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-linking of actin and fibrin by fibrin-stabilizing factor.
    Mui PT; Ganguly P
    Am J Physiol; 1977 Sep; 233(3):H346-9. PubMed ID: 910923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
    Lorand L
    Ann N Y Acad Sci; 2001; 936():291-311. PubMed ID: 11460485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of fibrinogen crosslinking sites in the absence of thrombin.
    Seelich T; Furlan M; Beck EA
    Thromb Haemost; 1976 Jun; 35(3):620-7. PubMed ID: 10637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.
    Achyuthan KE; Rowland TC; Birckbichler PJ; Lee KN; Bishop PD; Achyuthan AM
    Mol Cell Biochem; 1996 Sep; 162(1):43-9. PubMed ID: 8905624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.